Search results for "T-cell vaccination"

showing 9 items of 9 documents

Mechanisms of resistance to autoimmune disease induced by T-cell vaccination.

1991

Many human autoimmune diseases tend to progress slowly. Phases of rapid progression may come to a halt and may be followed by transient or even permanent remissions. Autoimmune diseases in animals either arise spontaneously or are induced. The former tend to be slowly progressive, the latter mostly acute to subacute, and usually followed by spontaneous remissions. The mechanisms at work that prevent rapid disease progression and can effect remissions are poorly understood, but they may provide us with a clue both to natural self-tolerance and to the therapeutic induction of self-tolerance.

Autoimmune diseaseEncephalomyelitis Autoimmune Experimentalbusiness.industrymedicine.medical_treatmentEncephalomyelitisT-LymphocytesImmunologyExperimental autoimmune encephalomyelitisT-cell vaccinationImmunization PassiveImmunotherapymedicine.diseaseImmune toleranceAutoimmune DiseasesVaccinationImmunoglobulin IdiotypesImmunopathologyImmunologymedicineImmune ToleranceImmunology and AllergyAnimalsbusinessAutoimmunity
researchProduct

Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.

1999

Myelin basic protein (MBP)-reactive T cells may play an important role in the autoimmune pathogenesis of multiple sclerosis (MS). MBP-reactive T cells can be specifically targeted by T cell vaccination, a procedure whereby MS patients are immunized with attenuated autologous MBP reactive T cells. T cell vaccination induces immune responses to the vaccine cells together with a depletion of MBP reactive T cells. Forty-nine MS patients were treated with T cell vaccination in an extended phase I trial to study the safety, immune responses and clinical effects of T cell vaccination. In the present paper the immune responses towards the vaccine cells were characterized. Substantial long-term in v…

CD4-Positive T-LymphocytesMultiple SclerosisT-LymphocytesImmunologyT-cell vaccinationLymphocyte ActivationInterleukin 21Immunology and AllergyMedicineCytotoxic T cellHumansIL-2 receptorAntigen-presenting cellImmunity CellularVaccinesCD40biologyClinical Trials Phase I as Topicbusiness.industryVaccinationMyelin Basic ProteinNatural killer T cellLymphocyte SubsetsVaccines InactivatedCTLA-4ImmunologyAntibody Formationbiology.proteinCytokinesImmunotherapybusinessJournal of autoimmunity
researchProduct

Inhibition of the mixed lymphocyte reaction by T cell vaccination

1990

Immunization with attenuated activated autoreactive T cell lines and clones induces a response in syngeneic animals which can induce protection or recovery from autoimmune disease. This process has been termed T cell vaccination. The aim of the present study was to investigate the effect of immunization with MHC-reactive T cells on the mixed lymphocyte reaction (MLR). By injecting attenuated activated T cells primed for an alloantigen, we markedly reduced the MLR in both rats and mice. This depression appeared to be mediated by active suppression; lymphoid cells from T cell-vaccinated animals suppressed the MLR responsiveness of T cells from naive animals. Suppression of the MLR was not res…

Encephalomyelitis Autoimmune ExperimentalT-LymphocytesT cellImmunologyReceptors Antigen T-CellT-cell vaccinationMice Inbred Strainschemical and pharmacologic phenomenaBiologyLymphocyte ActivationImmunotherapy AdoptiveMiceInterleukin 21Immune TolerancemedicineAnimalsImmunology and AllergyCytotoxic T cellIL-2 receptorAntigen-presenting cellfungiRats Inbred Strainshemic and immune systemsT lymphocyteNatural killer T cellRatsmedicine.anatomical_structureImmunologyFemaleLymphocyte Culture Test MixedEuropean Journal of Immunology
researchProduct

Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination

1992

Encephalomyelitis Autoimmune Experimentalbusiness.industryT-LymphocytesEncephalomyelitismedicine.medical_treatmentVaccinationImmunologyT-cell vaccinationAutoimmunityGeneral MedicineT lymphocyteImmunotherapymedicine.diseasemedicine.disease_causeAutoimmunityImmune toleranceVaccinationImmunopathologyImmunologyImmune TolerancemedicineAnimalsHumansImmunotherapybusinessSpringer Seminars in Immunopathology
researchProduct

Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression

1998

Patients with autoimmune hepatitis (AIH) usually require immunosuppressive therapy for many years, if not for a lifetime. Experimental immunotherapy such as T-cell vaccination aims at manipulating the immune system in such a way that autoimmunity is specifically regulated to enable long-lasting correction of the disease process. We aimed to test the feasibility of T-cell vaccination as well as conventional immunosuppression in the murine model of experimental autoimmune hepatitis (EAH). EAH was induced in 5- to 7-week-old BALB/c mice by immunization with syngeneic liver homogenate in complete Freund's adjuvant. For T-cell vaccination, splenocytes were removed from animals 14 days after indu…

Hepatologybusiness.industrymedicine.medical_treatmentT-cell vaccinationImmunosuppressionImmunotherapyAutoimmune hepatitismedicine.disease_causemedicine.diseaseAutoimmunityVaccinationImmune systemImmunizationImmunologymedicinebusinessHepatology
researchProduct

Humoral Mechanisms in T cell Vaccination: Induction and Functional Characterization of Anti-lymphocytic Autoantibodies

1997

T cell vaccination, the application of syngeneic attenuated T cells, has been shown to prevent effectively and treat experimental autoimmune diseases, but its mechanisms of action are poorly understood. Here we present data on the induction of a humoral anti-T cell response by T cell vaccination, capable of strongly inhibiting T cell proliferation and of ameliorating experimental autoimmune disease. T cell vaccination in the Lewis rat induced autoantibodies reactive with several syngeneic T cell proteins. These autoantibodies were not detectable in normal Lewis sera as assessed by immunoblotting and flow cytometry with intact syngeneic T cells. The autoantibody reactivity was not restricted…

IdiotypeEncephalomyelitis Autoimmune ExperimentalT-LymphocytesT cellImmunologyT-cell vaccinationBiologyLymphocyte ActivationImmunoglobulin IdiotypesmedicineAnimalsImmunology and AllergyCytotoxic T cellAntilymphocyte SerumAutoantibodiesImmune SeraVaccinationAutoantibodyMembrane ProteinsT lymphocyteClone CellsRatsmedicine.anatomical_structureRats Inbred LewImmunologyHumoral immunitybiology.proteinAntibodyJournal of Autoimmunity
researchProduct

Induction of an Anti-Vaccine Response by T Cell Vaccination in Non-human Primates and Humans

1993

Abstract Experimental and spontaneous autoimmune disease in animals can effectively be prevented and treated by application of pathogenic autoreactive T cells in an attenuated form. This approach has become known as T cell vaccination, T cell vaccination exploits specifically the ability of the immune system to regulate its autoreactive T cells by mechanisms of network control. The success of T cell vaccination in a variety of rodent animal models has raised hopes for its use as an effective and specific therapy in human autoimmune disease. The aim of this study was to induce an anti-T cell response by T cell vaccination in humans and primates as a pre-clinical study into the feasibility an…

MaleRegulatory T cellT-LymphocytesT cellLymphocyte CooperationImmunologyT-cell vaccinationAutoimmune DiseasesArthritis RheumatoidImmune systemAnimalsHumansImmunology and AllergyMedicineAntilymphocyte SerumAutoimmune diseasebusiness.industryVaccinationToxoidT lymphocyteMiddle Agedmedicine.diseaseMacaca mulattaVaccinationmedicine.anatomical_structureImmunologyFeasibility StudiesFemalebusinessJournal of Autoimmunity
researchProduct

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.

2005

Induction of high frequencies of specific T cells by vaccination requires prime-boost regimens. To reach optimal immune responses, it is necessary to use different vectors for priming and boosting as e.g. DNA vaccination followed by boosting with a recombinant viral vector. Here, we show that vaccines based on virus-like particles (VLP) displaying peptide epitopes are equally effective to induce CTL responses if used in a homologous or heterologous prime-boost setting. Strikingly, high frequencies (>20% of CD8(+) cells) of protective CTL could be induced and maintained by weekly injection of VLP. Thus, the use of VLP may avoid the requirement for complicated heterologous prime-boost regi…

T cellvirusesT-LymphocytesImmunologyT-cell vaccinationPriming (immunology)HeterologousEpitopes T-LymphocyteVaccinia virusBiologycomplex mixturesEpitopeViral vectorDNA vaccinationMicemedicineVaccines DNAVacciniaImmunology and AllergyAnimalsVaccinationVirionViral VaccinesVirologyHepatitis B Core AntigensCTL*medicine.anatomical_structureImmunologyCpG IslandsFemale
researchProduct

T-Cell Vaccination in Patients with Nickel Allergic Contact Dermatitis

1995

business.industryT-LymphocytesT-cell vaccinationCell BiologyDermatologymedicine.diseaseImmunotherapy AdoptiveBiochemistryNickelDermatitis Allergic ContactImmunologyHumansMedicineIn patientbusinessMolecular BiologyAllergic contact dermatitisJournal of Investigative Dermatology
researchProduct